Entering text into the input field will update the search result below

Marinus Pharmaceuticals GAAP EPS of -$1.06 misses by $0.37, revenue of $1.8M misses by $0.51M

Aug. 11, 2022 7:34 AM ETMarinus Pharmaceuticals, Inc. (MRNS) StockBy: Deepa Sarvaiya, SA News Editor
  • Marinus Pharmaceuticals press release (NASDAQ:MRNS): Q2 GAAP EPS of -$1.06 misses by $0.37.
  • Revenue of $1.8M (-5.8% Y/Y) misses by $0.51M.
  • GUIDANCE
  • For the fiscal year 2022, the Company expects BARDA revenues in the range of $7 to $10 million and total GAAP

Recommended For You

More Trending News

About MRNS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MRNS--
Marinus Pharmaceuticals, Inc.